NCT06248268 (NePsyAssip HT) is a clinical trial of (Neuro-)psychological assessment in Inhibitory Control, sponsored by University of Bern.

Who is sponsoring NCT06248268?

NCT06248268 is sponsored by University of Bern.

What drugs are being tested in NCT06248268?

Interventions in NCT06248268: (Neuro-)psychological assessment.

What condition does NCT06248268 study?

NCT06248268 studies Inhibitory Control, Locus of Control, Self Efficacy, Suicide, Attempted, Suicidal Ideation, Attention.

Is NCT06248268 still recruiting?

NCT06248268 is currently recruiting now. Last updated 16 January 2026.

Last reviewed 2026-01-16 · How we verify

NCT06248268: NePsyAssip HT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuropsychological Patterns of Suicide Ideators and Suicide Attempters

Recruiting now Last updated 16 January 2026

What this trial tests

trial testing (Neuro-)psychological assessment in Inhibitory Control in 180 participants. Currently enrolling.

Timeline

8 August 2024

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	University of Bern
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	180
Start date	8 August 2024
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across Switzerland

Drugs / interventions tested

(Neuro-)psychological assessment

Conditions studied

Inhibitory Control — all drugs for Inhibitory Control →
Locus of Control — all drugs for Locus of Control →
Self Efficacy — all drugs for Self Efficacy →
Suicide, Attempted — all drugs for Suicide, Attempted →

Sponsor

University of Bern

Who can join

18 and older, any sex, with Inhibitory Control or Locus of Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment. The overall aim of project 1 is to determine (neuro-) psychological differences between suicide attempters, suicide ideators, a clinical control group, and healthy controls. Study participants in project 1 will participate in a one-time (neuro-) psychological assessment. Project 1 of this study is an observational cross-sectional study with four groups that will be conducted at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland): Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort, without neither suicidal behavior or ideation (CLIN) and the healthy group (HLTH). The cohorts to be examined (SUAT \& SUID) will be compared to the two control groups (CLIN \& HLTH). Only people who have signed the informed consent and meet the eligibility criteria can participate in this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Inhibitory Control

Currently open trials in the same condition.

NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06916221 — BID LTM Digital Intervention in Aging · NA · recruiting
NCT06918704 — BID WM Digital Intervention in Aging · NA · recruiting

Other University of Bern trials

Trials by the same sponsor.

NCT05940662 — Cost Effectiveness of Various Implant Placement Protocols in the Esthetic Zone · Phase 4 · suspended
NCT02919163 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7) · NA · not yet recruiting
NCT02919189 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 5 of 7) · NA · not yet recruiting
NCT04817592 — Characterization of the Corneal Biomechanics of Patients Treated by Corneal Lenticule Extraction for Advanced Refractive · not yet recruiting
NCT06806150 — The INSPIRE Study: INvestigation of Swiss Physicians Inner-life, Resilience, and Emotions · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06248268 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bern
Last refreshed: 16 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06248268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing